
About Nexus NeuroTech Ventures
Nexus NeuroTech Ventures is a Healthcare company based in San Francisco (United States) founded in 2023. Investments are focused on neurotechnology for brain disorders. It operates on a HealthTech model. Nexus NeuroTech Ventures offers products and services including Neurotechnology Investments. Its focus areas include Medical Technology and Neurotechnology.
Company details
Nexus NeuroTech Ventures is dedicated to supporting breakthrough technologies for brain disorders. Investments are made in solutions addressing neurodegenerative, neuropsychiatric, and neurodevelopmental conditions such as Parkinsons disease, bipolar disorder, and autism spectrum disorder. The portfolio is built to include diagnostic and management technologies, spanning less invasive to more invasive medical interventions, software- and hardware-based diagnostics, data platforms for clinical trials, and tools for clinical research and care. A holistic approach is adopted to tackle brain disorders through innovative healthcare solutions.
- Headquarters San Francisco, United States
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website nexusneurotech.com
- Social LinkedIn
Products & Services of Nexus NeuroTech Ventures
Nexus NeuroTech Ventures offers a comprehensive portfolio of products and services, including Neurotechnology Investments.
Investments are made in neurotechnology for brain disorders.
Top companies in Neurology
3 companies that operate in the same segment as Nexus NeuroTech Ventures (Neurology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Developer of therapeutics for psychiatric and neurologic diseases | 2002 | New York, New York, United States | USD 80.87 M | USD 250.31 M | 600 | |
Biologics platform developed for intracellular delivery in rare diseases. | 2016 | Boston, Massachusetts, United States | USD 175.25 M | USD 25.42 M | 183 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Nexus NeuroTech Ventures
Nexus NeuroTech Ventures was founded in 2023.
Nexus NeuroTech Ventures is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Nexus NeuroTech Ventures is dedicated to supporting breakthrough technologies for brain disorders. Investments are made in solutions addressing neurodegenerative, neuropsychiatric, and neurodevelopmental conditions such as Parkinsons disease, bipolar disorder, and autism spectrum disorder. The portfolio is built to include diagnostic and management technologies, spanning less invasive to more invasive medical interventions, software- and hardware-based diagnostics, data platforms for clinical trials, and tools for clinical research and care. A holistic approach is adopted to tackle brain disorders through innovative healthcare solutions.
Nexus NeuroTech Ventures offers Neurotechnology Investments.